Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year...

Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal
Year 2008 Results on May 29, 2008

DETROIT, May 20 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical
Laboratories, Ltd. (Amex: CPD) announced that the Company will release results
for its fourth quarter and fiscal year 2008 ended March 31, 2008, prior to the
market opening on Thursday May 29, 2008.
Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops,
manufactures, markets and distributes generic and private-label
pharmaceuticals to the nation's largest wholesalers, distributors, drugstore
chains and managed care providers.
Safe Harbor: This news release contains forward-looking statements made
pursuant to the safe-harbor provisions of the Private Securities Litigation
Reform Act of 1995. Such statements are based on management's current
expectations and are subject to risks and uncertainties that could cause
actual results to differ materially from those described in the
forward- looking statements. These risks and uncertainties are contained in
the Corporation's filings with the Securities and Exchange Commission and
include, but are not limited to: information of a preliminary nature that may
be subject to adjustment, potentially not obtaining or delay in obtaining FDA
approval for new products, governmental restrictions on the sale of certain
products, development by competitors of new or superior products or cheaper
products or new technology for the production of products, the entry into the
market of new competitors, market and customer acceptance and demand for new
pharmaceutical products, availability of raw materials, timing and success of
product development and launches, dependence on few products generating
majority of sales, product liability claims for which the Company may be
inadequately insured, and other risks identified in this report and from time
to time in our periodic reports and registration statements. These
forward- looking statements represent our judgment as of the date of this
report. We disclaim, however, any intent or obligation to update our
forward-looking statements.
SOURCE Caraco Pharmaceutical Laboratories, Ltd.

Daniel Movens, +1-313-871-8400, or Aaron Miles, +1-313-556-4150, both of
Caraco Pharmaceutical Laboratories, Ltd.